Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)

Clinical trial NCT03909529 · COMPLETED

Trial details

NCT number: NCT03909529
Sponsor: CMP Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction

Start date: 2019-03-10
Primary completion: 2019-04-19
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.